tert-Butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate

Catalog No. :
ACZKGA572
CAS No. :
2891580-02-0
Molecular Formula :
C11H20N2O2
Molecular Weight :
212.29

IUPAC Name:tert-butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate

tert-Butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$321.00Login to see priceIn stockInquiry
250mg95%$533.00Login to see priceIn stockInquiry
1g95%$1075.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate
IUPAC Nametert-butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate
MDL No.MFCD34646444
Molecular FormulaC11H20N2O2
Molecular Weight212.29
SMILESCC(C)(OC(N1[C@@H](C2(C1)CNC2)C)=O)C
InChI KeyUPVHXFWKQXDWPM-MRVPVSSYSA-N
Synonym1,1-Dimethylethyl (1R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate;tert-butyl (3R)-3-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate;tert-Butyl (R)-1-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate;tert-butyl (3R)-3-methyl-2,6-diazaspiro[3.3]heptane-2-carboxylate - [B86397]
CAS No.2891580-02-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZKGA572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZKGA572 route product structure diagram
    ACZKGA5722891580-02-0 In Stock
Inquiry

2. ACZKGA572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZKGA572 route product structure diagram
    ACZKGA5722891580-02-0 In Stock
Inquiry

Comments (0)